Why the study?
Finding a causal mutation in hypertrophic cardiomyopathy helps assess proband risk, evaluate relatives, and focus follow-up on carriers.
Design
Observational study
Follow-up
Median of 63 months
Authors
Loading...
p.Arg652Lys carriers show high HCM penetrance and events; extends MYH7 data but leaves open prospective validation.
The novel p.Arg652Lys variant in the MYH7 gene is likely pathogenic and associated with the development of hypertrophic cardiomyopathy and serious adverse cardiovascular events.
Antoniutti et al. (2022) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: